Not only Pfizer is arguing, but all medical authorities in the world have expressed their opinions on this new drug, and various doubts and questions are pouring in.
As stated in the paper, there are two points that are most likely to be criticized.
The first is that there are too few clinical data, with only a dozen cases.
The second is that the treatment time is too short, only one month, which can only prove the short-term effectiveness.
This is different from the drugs used to treat cancer. Cancer is fatal to many people, and the condition worsens quickly. A person may die within a few months.
However, Alzheimer's disease is not fatal. Patients can generally live for 8-10 years. If cared for well, it is not impossible to live for more than ten or twenty years.
These patients have been taking drugs for a long time to control their conditions, and they have various chronic diseases and are taking other drugs.
There may be no problems with a drug in the short term, but if you take it for one or two years, or even five or six years, the possibility of causing cancer or other fatal diseases will be greatly increased.
Therefore, long-term clinical trials are needed to confirm the safety and side effects of drugs that are taken for a long time.
As for drug resistance caused by long-term use, that is another problem. In short, the standards for long-term drugs and immediate-acting drugs are different.
Controversy is often accompanied by hot traffic. Sanqing, a special drug, is already popular while it is still in clinical trials. It is not only popular in China, but also popular all over the world.
More and more patients and family members learned the news from the Internet and the news, and they were all ecstatic.
Domestic patients are anxiously contacting the relevant personnel of Sanqing to ask where they can participate in subsequent clinical trials.
Foreign patients can only post online, hoping that Sanqing, a special drug, can be launched in their country as soon as possible to benefit patients around the world.
Because compared to cancer, this kind of forgetting your family and even forgetting yourself is more painful.
And this pain does not only last for a while, but will continue until the end of the patient's life.
What’s even more frightening is that caring for an elderly person suffering from Alzheimer’s disease is even more troublesome than caring for an elderly person who is paralyzed.
This means that for at least 5-10 years, not only will the patient suffer, but the pain caused to the family will be endless, and it will even be a double mental and physical torture.
Therefore, after reading the controversy of online experts, patients expressed their support, saying that if it could help Alzheimer's patients regain their memory and stay awake, they would be willing to try it, even if there were other side effects.
Netizens have even begun to discuss heatedly on the Internet, which one is more important to human beings, life or memory.
"Live incomplete or die complete, which one will you choose?"
"I choose memory. Even if you get poisoned or get cancer after taking this medicine, there are ways to deal with these. At least you can live like a human being and die with the dignity of a primate at the top of the food chain."
"Me too, at least you can know who you are, recognize your family, you can call your son and wife by their names again, and you can even walk out of the house, look at your neighbor and say, Hi, George, old fool, do you still remember me? Is it? I'm back again. Is there anything better than this? At that moment, even if I die immediately afterwards, I feel it's worth it."
"I would like to ask these experts, have you ever had a family member with Alzheimer's disease? Do you understand the pain that such a patient brings to the family members? If not, then shut your mouth and tell the truth about the pain that is really effective. Give us medicine, not whining."
"People who have never experienced it will never know that kind of experience. My father was diagnosed with this disease three years ago. Losing memory is not the most painful thing. The most painful thing is losing your dignity as a human being. With this disease, you are like Like animals, they will lose all knowledge of the world. One day, I came home and saw with my own eyes that my father, who was once a university professor, put his hand into the toilet, splashing the water while watching curiously. From there, From that moment I knew I had lost him completely."
"Alzheimer's disease is inherited in my family. This disease is a nightmare for me, and it is a nightmare that I can never wake up from. I watched my grandmother and mother get sick one after another. My mother took care of my grandmother all her life. , after she found out that she had a disease, she decisively committed suicide by taking a gun. In her last words, she said that she could not accept that it would drag me down for the rest of my life, and I already planned to spend the rest of my life alone. When I get sick, I will too. Swallow a bottle of sleeping pills. I will never bring this pain to anyone again."
"Poor Amy0021, God bless you!"
The debate raged online, with patients' voices overwhelmingly winning out.
After all, no one likes to live like a zombie, forgetting family and friends, forgetting the past, and forgetting everything.
Sanqing is happy to see the controversy on the Internet. After all, the longer the debate lasts, the more people will participate in the debate. After this drug is launched in the future, more people will believe in its efficacy and be willing to accept it. treat.
However, in order to take care of the patients who came to its door, Sanqing contacted well-known tertiary hospitals in Haishi and Beijing to carry out phase II clinical trials.
In order to master more case data and quell the controversy as soon as possible, the number of people in each place has been increased to 500. After the second phase, the third phase of clinical trials will continue, and the number of people will increase to more than 1,000.
In short, as long as the second phase of clinical trials for these 1,500 people is completed and there are real and effective treatment data, any controversy can be settled.
Because Mr. Xie's illness was cured and he was allowed to return to work, both academicians Mr. Xie and Mr. Qi strongly recommended him to their superiors.
Therefore, as a domestic innovative drug that fills the current treatment gap in this field and has breakthrough results, Sanqing, a special drug, has gained a green channel.
After the completion of the second phase of clinical trials, the third phase of clinical trials will be carried out as quickly as possible, and the marketing approval process will also be simplified.
The purpose is to treat more patients as quickly as possible so that they can recover as soon as possible and return to their families like normal people.
At this moment, amid heated discussions around the world, Eagle Country’s Fox News published a ground-breaking report.
“Is it originality or theft? On the ins and outs of Sanqing’s special drug for Alzheimer’s disease!”
"The recently popular Sanqing special medicine is actually not an original new drug, but a theft of Pfizer's technology and patents."
"As we all know, Pfizer announced four years ago that it would abandon the research and development of neurodegenerative diseases such as Alzheimer's disease. The project was stopped, the experts were dismissed, and the patents and technology were dusted. At that time, there was a Chinese expert who returned to China immediately after leaving. No one I don’t know why he was so anxious in the first place and whether there was any hidden secret.”
"This Chinese chemist is named Chen Yiqing. He received a doctorate from Harvard. He could have stayed in the Eagle Country Pharmaceutical Company and had a bright future, but he immediately ran away and returned to China after the project was stopped. Four years later, he joined Sanqing In just a few months, Pfizer has successfully developed a new and effective drug based on Pfizer's original research direction. Is this a coincidence or an inevitable outcome?"
"We interviewed several of Chen's former colleagues, all of whom have left their jobs to join other pharmaceutical companies. They all reported that Chen worked very hard and was very active in learning related technologies. He was even interested in many unrelated technologies. Such a studious and motivated person, however, after the project was disbanded, he rejected the promotion notice and resolutely returned to China. This attitude is very evocative, and the whole thing is also thought-provoking."
"In fact, they all said that the research at Pfizer was about to make a breakthrough, but was stopped by the board of directors. This is a very regrettable thing. They have no doubt that Chen can develop specific drugs based on this, and said congratulate."
"Next, please watch our reporters' special interviews with relevant people..."
This news report was like igniting a bomb, instantly pushing Sanqing's special medicine to the forefront.
